Abstract
The worldwide threat from tuberculosis (TB) has resulted in great demand for new drugs, particularly those that can treat multidrug-resistant TB. We synthesized novel pleuromutilin derivatives with N-benzylamine side chain substituted at the C14 position and evaluated their activity in vitro against a virulent strain of Mycobacterium tuberculosis (H37Rv). The primary assay results showed that five compounds inhibited the H37Rv at 20 μM, with a MIC of one of the analogues as low as 7.2 μM.
Original language | English |
---|---|
Pages (from-to) | 1799-1803 |
Number of pages | 5 |
Journal | Bioorganic and Medicinal Chemistry Letters |
Volume | 25 |
Issue number | 8 |
DOIs | |
Publication status | Published - 15 Apr 2015 |
Keywords
- Antitubercular activity
- N-Benzylamine side chain
- Pleuromutilin derivatives